MILLA, Paola

MILLA, Paola  

SCIENZA E TECNOLOGIA DEL FARMACO  

Mostra records
Risultati 1 - 20 di 76 (tempo di esecuzione: 0.027 secondi).
Titolo Data di pubblicazione Autore(i) File
2,3-oxidosqualene cyclase from yeast: a target enzyme for drug discovery. 1996 Milla P.; Balliano G.; Ceruti M.; Cattel L.
A Pharmacokinetics Study to Optimize Intravesical Administration of Gemcitabine 2008 Paolo Gontero; Luigi Cattel; Tonia C. Paone; Giovanna Berta; Paola Milla; Francesco Carbone; Claudio Medana; Alessandro Tizzani
A pharmacokinetics study to optimize intravesical administration of gemcitabine 2009 Paolo Gontero; Luigi Cattel; Giovanna Berta; Tonia C. Paone; Paola Milla; Claudio Medana; Francesco Carbone; Alessandro Tizzani
Administration of reduced glutathione in FOLFOX4 regimen in advanced colorectal cancer: effect on oxaliplatin pharmacokinetics and on Pt-DNA adducts formation 2007 M. Airoldi; P. Milla; L. Cattel; I. Gozzelino; A. Drescher; U. Jaehde; L. Branciforte; F. Pedani
Alternate scheduling of Gemcitabine (GEM) - Oxaliplatin (OXA) association in metastatic (MTS) or locally advanced (LA) pancreatic adenocarcinoma: a clinical and pharmacokinetic (pk) evaluation 2004 Airoldi M; Cattel L; Pedani F; Micari C; Nigro A; Branciforte L; Zanon C; Milla P
Anti-TNF-α drugs: pharmacoeconomic analysis and proper use in pharmacological treatment in rheumatoid arthritis 2012 C. Francisco; C. Marongiu; V. Azzolini; P. Milla; V. Modena
Association of Gemcitabine (GEM) and Oxaliplatin (OXA) in metastatic or locally advanced pancreatic adenocarcinoma: a clinical and pharmacokinetic (PK) study 2004 Airoldi M; Cattel L; Passera R; Micari C; Nigro A; Milla P
Coagulation Factor VIII: pharmacoeconomic evaluation and quality of life as measuring tools in clinical practice 2012 F. Donato; M. Ferroni; M. Messina; P. Schinco; M. Marengo; A. Elia; F. Cattel; P. Milla; M. Miglietta; L. Cattel
Comparative properties of N-ethoxycarbonyl-D-phenylalanyl-L-prolyl-alpha-azalysine p-nitrophenyl ester and N-ethoxycarbonyl-D-phenylalanyl-alpha-azaprolyl-L-lysine p-nitrophenyl ester as subsrates of serine proteinases 1997 Milla P; Balliano G; Gallina C; Ascenzi P
Comparison of the mechanism of yeast oxidosqualene cyclase and bacterial squalene cyclase by using rationally designed inhibitors. 1999 Milla P.; Balliano G.; Viola F.; Ceruti M.; Cattel L.; Poralla K.
Design of specific tools to evaluate the Cost Of Illness (COI) of Rheumatoid Arthritis 2013 Marongiu C.; Francisco C.; Milla P.; Gallicchio M.; Cattel L.; Azzolini V.
Drug delivery systems from the University of Turin. 2013 F. Dosio; S. Arpicco; B. Stella; P. Milla
Economic evaluation of different modalities of immunoglobulin therapy in chronic dysimmune polyradiculoneuropathies 2012 D. Cocito; G. Serra; I. Paolasso; Y. Falcone; D.A. Barilà; P. Milla; L. Cattel
Effect of proteases on microsomal oxidosqualene cyclases from Saccharomyces cerevisiae and Candida albicans 1995 Milla P; Balliano G; Viola F; Giacotto M E; Cattel L
Effect of proteases on microsomal oxidosqualene cyclases from Saccharomyces cerevisiae and Candida albicans 1995 Milla P; Balliano G; Viola F; Giacotto M E; Cattel L
Effects of reduced glutathione (GSH) on oxaliplatin (OXA) in advanced colorectal cancer treated by FOLFOX4 regimen: Pharmacokinetics (PK) and determination of PtDNA adducts 2007 Airoldi M; Cattel L; Milla P; Drescher A; Jaehde U; Gozzelino I; Branciforte L; Pedani F
Effects of reduced glutathione (GSH) on oxaliplatin pharmacokinetics (OXA pk) and on Pt-DNA adducts formation in advanced colorectal cancer patients treated by FOLFOX4 regimen 2007 C. Zanon; M. Airoldi; R. Passera; L. Cattel; P. Milla; U. Jaehde; A. Drescher; L. Branciforte; I. Gozzelino; F. Pedani
Evidence of the existence of an essential thiol group within the active site of oxidosqualene cyclase from Saccharomyces cerevisiae 1992 Balliano G; Grosa G; Milla P; Viola F; Cattel L
Farmacocinetica del paclitaxel in associazione con acido valproico nella terapia del tumore anaplastico della tiroide 2009 Scaldaferri M; Potenzieri A; Milla P; Tomatis L; Scotognella T; Michelon F; Poli R; Cattel L
Farmacocinetica della Gemcitabina (GEM) e del suo trifosfato (dFdCTP) in infusione prolungata a basse dosi in monochemioterapia in pazienti affetti da tumori solidi 2004 Ferrarato E; Di Franco M; Nigro A; Micari C; Milla P; Cattel L